Ignite Creation Date:
2024-10-25 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06542614
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
Treatment of Moderate to Severe Plaque Psoriasis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase II Clinical Trial to Evaluate the Efficacy Safety Pharmacokinetics PK and Pharmacodynamic PD Profile of TQH3906 in Subjects With Moderate to Severe Plaque Psoriasis
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis as well as the PK and PD characteristics of multiple doses
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None